According to the sources provided, Keytruda is a biologic drug used in the treatment of various types of cancer. When comparing the cost of Keytruda with its competitors, it is important to consider factors such as pricing strategies, discounts, and availability in different markets.
The first source, Drug Patent Watch, provides information about the patent status of Keytruda. While it does not directly address the cost of the drug, it can be inferred that the expiration of patents may lead to the introduction of generic versions, which could potentially reduce the cost of Keytruda in the future.
The second source, Drugs.com, allows for a comparison of Keytruda with other drugs. However, it does not provide specific pricing information. It is important to note that drug prices can vary depending on factors such as the country, healthcare system, and insurance coverage.
The third source, FiercePharma, mentions a competitor drug called Loqtorzi, which is a China-made PD-1 drug. The article states that Coherus, the manufacturer of Loqtorzi, priced the drug at a 20% discount compared to Keytruda in China. This suggests that Keytruda may be relatively more expensive than Loqtorzi in the Chinese market.
Based on the provided sources, it is difficult to make a definitive statement about whether Keytruda is cheaper than its competitors. Pricing information for Keytruda itself is not explicitly mentioned in the sources. Additionally, the cost of drugs can vary depending on various factors, such as location and discounts offered by manufacturers.
In order to obtain accurate and up-to-date pricing information for Keytruda and its competitors, it is recommended to consult with healthcare professionals, insurance providers, or refer to reliable sources such as official drug pricing databases or pharmaceutical companies' websites.
Sources:
[1] Drug Patent Watch - https://www.drugpatentwatch.com/p/biologics/tradename/KEYTRUDA
[2] Drugs.com - https://www.drugs.com/compare/keytruda
[3] FiercePharma - https://www.fiercepharma.com/marketing/coherus-prices-china-made-pd-1-drug-loqtorzi-20-discount-mercks-keytruda